₹4,000 crore revenue target by FY27-28
At current growth trajectory (~15% CAGR), management is confident of achieving the target ahead of schedule. Q3 run-rate of ₹858 crore and 9-month momentum support acceleration.
VIYASH / guidance tracker
Keep management guidance in view.
Viyash Scientific · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
20%+ EBITDA margin sustainability
Management explicitly stated 20% margins are now sustainable and will be maintained, supported by four-segment diversification and continuous cost optimization initiatives across API manufacturing.
15-20% minimum annual growth
While acknowledging Q3 EBITDA growth of 64% YoY represents one-time synergy realization, management targets minimum 15-20% annual growth across the merged entity going forward.
₹50-60 crore merger synergies realization
Network optimization and operational integration synergies on track to materialize over next 12-18 months, including corporate function restructuring and capacity utilization improvements.